Clinical Trial Update: Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

Phase 2 trial comparing three immunosuppressive regimens for severe aplastic anemia; results of the study have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Neutropenia
• Pancytopenia
• Thrombocytopenia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Immunosuppresion, Thrombocytopenia | Phase 2 | Status: COMPLETED | Results posted: 2017-06-08